Acridine Photocatalysis: Insights into the Mechanism and Development of a Dual-Catalytic Direct Decarboxylative Conjugate Addition
作者:Hang T. Dang、Graham C. Haug、Vu T. Nguyen、Ngan T. H. Vuong、Viet D. Nguyen、Hadi D. Arman、Oleg V. Larionov
DOI:10.1021/acscatal.0c03440
日期:2020.10.2
Conjugateaddition is one of the most synthetically useful carbon–carbon bond-forming reactions; however, reactive carbon nucleophiles are typically required to effect the addition. Radical conjugateaddition provides an avenue for replacing reactive nucleophiles with convenient radical precursors. Carboxylicacids can serve as simple and stable radical precursors by way of decarboxylation, but activation
The Palladium–Catalyzed Cross-Coupling Reaction of Enol Acetates of α-Bromo Ketones with 1-Alkenyl-, Aryl-, or Alkylboron Compounds; A Facile Synthesis of Ketones and Their Enol Acetates
作者:Shigeru Abe、Norio Miyaura、Akira Suzuki
DOI:10.1246/bcsj.65.2863
日期:1992.10
The synthesis of stereodefined enol acetates of ketones is readily accomplished by palladium–catalyzed cross-coupling reaction between alkyl-, aryl-, or 1-alkylboron reagents with enol acetates of α-bromo ketones. Hydroboration of alkene with 9-BBN, followed by coupling with (Z)-2-ethoxy-1-bromoethene gives the enol ether of aldehyde. These enol acetates and ethers are readily deprotected to give corresponding
Enolate Generation under Hydrogenation Conditions: Catalytic Aldol Cycloreduction of Keto-Enones
作者:Ryan R. Huddleston、Michael J. Krische
DOI:10.1021/ol0300219
日期:2003.4.1
[GRAPHIC]Formal heterolytic activation of elemental hydrogen under Rh catalysis enables the reductive generation of enolates from enones under hydrogenation conditions. Enolates generated in this fashion participate in catalytic C-C bond formation via carbonyl addition to aldehyde and, as demonstrated in this account, ketone partners. Notably, the use of appendant dione partners enables diastereoselective formation of cycloaidol products possessing 3-stereogenic centers, including 2-contiguous quaternary centers.
GLUCOSYLCERAMIDE SYNTHASE INHIBITION FOR THE TREATMENT OF COLLAPSING GLOMERULOPATHY AND OTHER GLOMERULAR DISEASE